GEODE CAPITAL MANAGEMENT, LLC: DRUG position timeline

GEODE CAPITAL MANAGEMENT, LLC held 104,146 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-12.

the latest 13F is the newest step

1. period ended2026-06-30

   13F 104,146 shares

   Change vs previous 13F +15,430 shares

   <0.01% of the 13F portfolio, value $7,311,049.

   13F-HR 0001214717-26-000008 filed by GEODE CAPITAL MANAGEMENT, LLC
   Filed 2026-08-12 (acceptance time not in the bulk data set), ingested 2026-10-06 09:57:27 UTC

   Acceptance time not in the bulk data set (spec §4.2).

2. period ended2026-03-31

   13F 88,716 shares

   Change vs previous 13F +25,170 shares

   <0.01% of the 13F portfolio, value $6,473,605.

   13F-HR 0001214717-26-000006 filed by GEODE CAPITAL MANAGEMENT, LLC
   Filed 2026-05-15 (acceptance time not in the bulk data set), ingested 2026-10-06 09:58:43 UTC

   Acceptance time not in the bulk data set (spec §4.2).

3. period ended2025-12-31

   13F 63,546 shares

   Change vs previous 13F +5,647 shares

   <0.01% of the 13F portfolio, value $4,959,129.

   13F-HR 0001214717-26-000003 filed by GEODE CAPITAL MANAGEMENT, LLC
   Filed 2026-02-09 (acceptance time not in the bulk data set), ingested 2026-10-07 03:01:36 UTC

   Acceptance time not in the bulk data set (spec §4.2).

4. period ended2025-09-30

   13F 57,899 shares

   Change vs previous 13F +378 shares

   <0.01% of the 13F portfolio, value $3,512,152.

   13F-HR 0001214717-25-000016 filed by GEODE CAPITAL MANAGEMENT, LLC
   Filed 2025-11-12 (acceptance time not in the bulk data set), ingested 2026-10-07 03:02:25 UTC

   Acceptance time not in the bulk data set (spec §4.2).

5. period ended2025-06-30

   13F 57,521 shares

   Change vs previous 13F not available

   <0.01% of the 13F portfolio, value $1,501,872.

   13F-HR 0001214717-25-000012 filed by GEODE CAPITAL MANAGEMENT, LLC
   Filed 2025-08-08 (acceptance time not in the bulk data set), ingested 2026-10-07 18:23:11 UTC

   Acceptance time not in the bulk data set (spec §4.2).